Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Memorial Sloan Kettering Cancer Center showed that a small group of chronic lymphocytic leukemia patients experienced treatment-resistant mutations in a clinical trial for Loxo-305 (pirtobrutinib).
Ross Levine was named deputy physician-in-chief of translational research at Memorial Hospital, the main Manhattan hospital for Memorial Sloan Kettering Cancer Center.
Craig Thompson said he would step down from his roles as president and CEO of Memorial Sloan Kettering Cancer Center.
Memorial Sloan Kettering Cancer Center announced the creation of The Marie-Josée and Henry R. Kravis Cancer Ecosystems Project, which aims to spur the next revolution of preclinical research, discovery, and treatment.
Memorial Sloan Kettering Cancer Center has created the Fiona and Stanley Druckenmiller Presidential Innovation Fund, which will seed projects in translational cancer medicine.
Rémy Evard has joined Memorial Sloan Kettering Cancer Center as chief digital officer and head of technology. He succeeds Claus Jensen, who left MSK in May 2021.
